Double-blind randomised placebo-controlled trial of bolus-dose vitamin D3 supplementation in adults with asthma (ViDiAs)

Rationale Asthma exacerbations are commonly precipitated by viral upper respiratory infections (URIs). Vitamin D insufficiency associates with susceptibility to URI in patients with asthma. Trials of vitamin D in adults with asthma with incidence of exacerbation and URI as primary outcome are lacking. Objective To conduct a randomised controlled trial of vitamin D3 supplementation for the prevention of asthma exacerbation and URI (coprimary outcomes). Measurements and methods 250 adults with asthma in London, UK were allocated to receive six 2-monthly oral doses of 3 mg vitamin D3 (n=125) or placebo (n=125) over 1 year. Secondary outcomes included asthma control test and St George's Respiratory Questionnaire scores, fractional exhaled nitric oxide and concentrations of inflammatory markers in induced sputum. Subgroup analyses were performed to determine whether effects of supplementation were modified by baseline vitamin D status or genotype for 34 single nucleotide polymorphisms in 11 vitamin D pathway genes. Main results 206/250 participants (82%) were vitamin D insufficient at baseline. Vitamin D3 did not influence time to first severe exacerbation (adjusted HR 1.02, 95% CI 0.69 to 1.53, p=0.91) or first URI (adjusted HR 0.87, 95% CI 0.64 to 1.16, p=0.34). No clinically important effect of vitamin D3 was seen on any of the secondary outcomes listed above. The influence of vitamin D3 on coprimary outcomes was not modified by baseline vitamin D status or genotype. Conclusions Bolus-dose vitamin D3 supplementation did not influence time to exacerbation or URI in a population of adults with asthma with a high prevalence of baseline vitamin D insufficiency. Trial registration number NCT00978315 (ClinicalTrials.gov).

[1]  David A. Jolliffe,et al.  Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. , 2015, The Lancet. Respiratory medicine.

[2]  Tonya S. King,et al.  Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial. , 2014, JAMA.

[3]  Madhu Yadav,et al.  Effect of Vitamin D Supplementation on Moderate to Severe Bronchial Asthma , 2014, The Indian Journal of Pediatrics.

[4]  S. Eldridge,et al.  S123 Increased risk of upper respiratory infection with addition of intermittent bolus-dose vitamin D supplementation to a daily low-dose regimen , 2013, Thorax.

[5]  C. Wagner,et al.  Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes. , 2013, The Journal of clinical endocrinology and metabolism.

[6]  David A. Jolliffe,et al.  Vitamin D in the prevention of acute respiratory infection: Systematic review of clinical studies , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[7]  D. Viswanath,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2012, Pediatrics.

[8]  S. Sunyaev,et al.  Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations. , 2012, The Journal of allergy and clinical immunology.

[9]  M. Decramer,et al.  High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease: A Randomized Trial , 2012 .

[10]  S. Johnston,et al.  Asthma exacerbations: Origin, effect, and prevention , 2011, Journal of Allergy and Clinical Immunology.

[11]  K. Smejda,et al.  Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. , 2011, The Journal of allergy and clinical immunology.

[12]  Christine L. Taylor,et al.  Dietary Reference Intakes for Calcium and Vitamin D , 2016, Pediatric Clinical Practice Guidelines & Policies.

[13]  G. Hunninghake,et al.  Vitamin D Decreases Respiratory Syncytial Virus Induction of NF-κB–Linked Chemokines and Cytokines in Airway Epithelium While Maintaining the Antiviral State , 2009, The Journal of Immunology.

[14]  R. Vieth.  How to optimize vitamin D supplementation to prevent cancer, based on cellular adaptation and hydroxylase enzymology. , 2009, Anticancer research.

[15]  C. Camargo,et al.  Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. , 2009, Archives of internal medicine.

[16]  R. Heaney,et al.  Pharmacokinetics of a single, large dose of cholecalciferol. , 2008, The American journal of clinical nutrition.

[17]  Robert J Wilkinson,et al.  A single dose of vitamin D enhances immunity to mycobacteria. , 2007, American journal of respiratory and critical care medicine.

[18]  M. Dallman,et al.  Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. , 2005, The Journal of clinical investigation.

[19]  P. Jones.  St. George's Respiratory Questionnaire: MCID , 2005, COPD.

[20]  Karl Ekdahl,et al.  'Did you have flu last week?' A telephone survey to estimate a point prevalence of influenza in the Swedish population. , 2005, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[21]  C. Griffiths,et al.  Specialist nurse intervention to reduce unscheduled asthma care in a deprived multiethnic area: the east London randomised controlled trial for high risk asthma (ELECTRA) , 2004, BMJ : British Medical Journal.

[22]  Philip Marcus,et al.  Development of the asthma control test: a survey for assessing asthma control. , 2004, The Journal of allergy and clinical immunology.

[23]  R. Doll,et al.  Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial , 2003, BMJ : British Medical Journal.

[24]  H. Minne,et al.  Vitamin D and Muscle Function , 2002, Osteoporosis International.

[25]  A Tattersfield,et al.  Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. , 2001, American journal of respiratory and critical care medicine.

[26]  K. Nicholson,et al.  Respiratory viruses and exacerbations of asthma in adults. , 1993, BMJ.

[27]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[28]  P. Jones,et al.  The St George's Respiratory Questionnaire. , 1991, Respiratory medicine.

[29]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[30]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[31]  D. Schoenfeld,et al.  Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. , 1982, Biometrics.

[32]  G. Jackson,et al.  Transmission of the common cold to volunteers under controlled conditions. III. The effect of chilling of the subjects upon susceptibility. , 1958, American journal of hygiene.

[33]  G. Jackson,et al.  Transmission of the common cold to volunteers under controlled conditions. I. The common cold as a clinical entity. , 1958, A.M.A. archives of internal medicine.